Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
Launched by CITY OF HOPE MEDICAL CENTER · Aug 25, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how light therapy combined with occupational therapy can help manage cancer-related fatigue (CRF) in patients with genitourinary cancers, such as bladder, kidney, and prostate cancer. Light therapy uses exposure to specific types of light to help improve energy levels and reduce feelings of tiredness, while occupational therapy focuses on helping patients engage in everyday activities. The goal is to see if this combination can make a positive difference for patients experiencing fatigue due to their cancer treatments.
To be eligible for this study, participants need to be 18 years or older, fluent in English, and currently receiving treatment for their cancer, like chemotherapy or radiation. They should also have mild to moderate fatigue as assessed by their doctor and a prognosis of at least six months. Participants will undergo regular sessions of light therapy and occupational therapy, and they can expect to be monitored for changes in their fatigue levels throughout the study. It's important to know that individuals with certain conditions, such as severe sleep disorders or eye diseases, won't be able to participate. This trial is currently recruiting participants, so it's a great opportunity for those looking for additional support in managing fatigue during their cancer journey.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 and over
- • Sufficiently fluent in English
- • On active treatment receiving systemic therapy (e.g., chemotherapy, immunotherapy, hormonal therapy, etc.) or radiotherapy
- • Patients with diagnosis of a genitourinary (GU) cancer (e.g., prostate, kidney, and bladder cancer) who have grade 1 or 2 fatigue based on physician assessment at the time of study entry
- • Clinician assessed prognosis of greater than or equal to six months
- • Willing and independently able to provide consent
- • Receive a pre-screen FACIT-Fatigue score of less than or equal to 30
- Exclusion Criteria:
- • Severe sleep disorders (e.g. narcolepsy)
- • Eye Diseases which limit the ability of light to be processed (e.g. untreated cataracts, severe glaucoma, macular degeneration, blindness, pupil dilation problems or other retinal disorder)
- • Severe psychological impairment (e.g., bipolar disorder or manic episodes)
- • Current employment in night shift work
- • Previous use of light therapy to alleviate fatigue or depressive symptoms
- • Secondary cancer diagnosis within the past 5 years
- • Plans to travel across meridians during treatment
- • Pregnancy
- • Currently recovering from previous eye surgery within the past 6 months that causes eye irritation
- • Sensitivity to light, epilepsy, or a history of seizures
About City Of Hope Medical Center
City of Hope Medical Center is a leading research and treatment institution located in Duarte, California, dedicated to advancing innovative therapies and improving patient outcomes in the fields of cancer, diabetes, and other life-threatening diseases. With a strong emphasis on translational medicine, City of Hope combines cutting-edge research with compassionate care, fostering a collaborative environment for clinical trials that aim to bring new treatments from the laboratory to the bedside. The center is recognized for its commitment to patient-centered care and its role as a National Cancer Institute-designated Comprehensive Cancer Center, making it a pivotal player in the landscape of medical research and clinical innovation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Duarte, California, United States
Patients applied
Trial Officials
William Dale
Principal Investigator
City of Hope Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials